HOME >> BIOLOGY >> NEWS
Popular Science outlines need for long-term studies and more regulation in A.R.T.

America Online to Carry Article Exclusively and Will Host Online Chat on Tuesday, February 11 at 8pm EST

New York, NY, February 6, 2003 -- In an article in its March issue (on newsstands February 11), Popular Science magazine describes the need for long-term studies and more regulation in assisted reproductive technology (ART). The article "Sallie has 2 Mommies & 1 Daddy," explores the science behind the risks of ART and the problems with the U.S. regulatory system that have allowed untested technologies to be used on patients for decades without oversight.

One in 11 couples in the United States is infertile. Desperation to have a child is widespread. Each year, thousands of these couples expose themselves and their future children to dangerous fertility treatments that were rushed from petri dishes to patients without regulation or human trials. About a million children have been born using assisted reproductive technology-otherwise known as ART-which has become so advanced, couples using it are statistically more likely to conceive a child than those relying on the old-fashioned natural approach.

The recent claim that a fringe group had cloned a human caused yet another wave of protests from scientists and politicians over reproductive cloning. It'll cause birth defects, they said, it'll create children with unimaginable problems. But with the spotlight on cloning, Americans missed one important point: For decades, fertility clinics have been doing precisely what scares experts about cloning. By using unregulated technologies on patients, they're creating children through experimental procedures with well-documented and potentially widespread risks. PopSci magazine's article examines and discusses the need for regulation and increased research into fertility methods.

The complete story can be found exclusively on AOL in the Health Channel (Keyword: Health Poll) beginning on February 6. Beginning on Monday, Feb
'"/>

Contact: Sara Delekta
sara.delekta@time4.com
917-868-4502
Popular Science
6-Feb-2003


Page: 1 2

Related biology news :

1. Popular Science announces Third Annual Brilliant 10
2. Popular Science announces second annual Brilliant 10: the countrys top young scientists
3. Popularizing precision agriculture
4. Popular weed killer feminizes native leopard frogs across Midwest
5. Popular weed killer disrupts frogs sexual development
6. Popular weed killer demasculinizes frogs, disrupts their sexual development
7. Popular pain analgesics found to affect central nervous system: Study identifies both peripheral and CNS mechanisms of action of NSAID use
8. Popular Diet Supplement May Be A Cancer Risk
9. Emu Meat Not A Popular Choice Among Consumers, Study Shows
10. New Studies Shed Light On Facial Features Of Popular Dinosaurs
11. Popular Cure-All Tea Can Cause Toxic Reactions

Post Your Comments:
(Date:3/2/2015)... VILNIUS, Lithuania , March 2, 2015   ... AI technologies, today introduced the SentiGaze Software Development ... developers to create applications that use off-the-shelf webcams to ... a user gazes at a monitor. Heatmaps can be ... determining the effectiveness of online advertising. The SDK can ...
(Date:2/23/2015)... , Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62114357 for DISTRIBUTED VOICE DIRECTED ... NXT-ID introduces a new groundbreaking payment method. Payment accounts ... account may only be accessed if both the speech ...
(Date:2/12/2015)... 12, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62/113114 for DISTRIBUTED METHOD AND SYSTEM TO ... patent further establishes NXT-ID,s position in the emerging "Internet ... the ability for multiple devices to collaborate with one ...
Breaking Biology News(10 mins):Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
(Date:3/4/2015)... 04, 2015 USDM Life Sciences ... life sciences industry, hired David Blewitt as ... Cloud Compliance Services and Solutions at USDM Life Sciences ... applications while maintaining compliance with government regulations worldwide. ... an accomplished life sciences regulatory and IS compliance professional ...
(Date:3/4/2015)... 2015 /CNW/ - Resverlogix Corp. (TSX:RVX) (the "Company") ... collaborative research program with Emerald Logic, a ... Evolution Technology (FACET), Emerald Logic analyzed Resverlogix,s ... from each of 798 patients who participated ... ASSERT, SUSTAIN and ASSURE. The objective of ...
(Date:3/4/2015)... 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of innovative therapies ... today announced that it will release fourth quarter ... on Monday, March 9th, 2015. AcelRx management will ... Eastern Time (1:30 p.m. Pacific Time) on March ...
(Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... Reaction (PCR) represents one of the fastest growing technologies ... cell biologists in subcellular visualization is driving growth in ... need for deeper understanding of gene expressions will continue ... market. Expanding applications in fields ranging from pharma, biotech, ...
Breaking Biology Technology:USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4
Cached News: